Auditing
As part of the European pharmacovigilance regulations defined in Good Pharmacovigilance Practices (GVP) each Marketing Authorisation Holder needs to regularly audit its pharmacovigilance system. This includes companies such as vendors, distributors, local PV representatives and co-licensees. GVP outlines the process each Marketing Authorisation Holder needs to follow in order to complete a risk assessment of each third party. Once the risk assessment is defined, the next step is to create the audit schedule and put in place the resources to conduct the required audits.
Diamond PV has conducted successful audits of UK and European pharmaceutical companies leading to favourable regulatory pharmacovigilance inspection outcomes. In order to ensure we are providing the best PV system in conjunction with our client, we undertake both self-audits and external audits. We provide a comprehensive assessment of the current systems in place and share advice on areas that require improvement. We have also been successfully inspected by the MHRA on several occasions.
Your approach to auditing will depend on your vendor management and audit processes. If needed, we can help you develop your standard operating procedures in this area. This includes your risk assessment of third parties and creation of an audit schedule.
Training
All staff who may potentially be contacted regarding an adverse drug reaction must be trained on how to recognise it, how to handle it, and what to do next. We can provide drug safety training to staff to ensure they meet these requirements.
We can offer more extensive training to suit individual needs, such as:
- Pharmacovigilance Auditing
- Volume 10 and Clinical Trials Directive Training
- Basic Pharmacovigilance Training for non PV staff
- Basic Pharmacovigilance Training for PV professionals
- Intermediate Pharmacovigilance Training for PV professionals
“Talk to Us”
Elizabeth Ursell is our Technical Director, based in Harlow (UK). If you would like to talk to us about third party risk assessment for pharmacovigilance, pharmacovigilance audits or training, please get touch with Elizabeth at: eursell@diamondpharmaservices.com
or call her on +44 (0) 203 911 9410

Contact
Please contact us for more details about our world leading services and our business development and operations team will provide answers to your questions.
Read MoreDiamond Acquires PharmaCentral to Strengthen Pharmacovigilance Division and Enhances Senior-level Expertise
Diamond Pharma Services acquires PharmaCentral to strengthen the pharmacovigilance division and to expand the organisation in Europe
Read MoreBeyond Brexit: Diamond Secures EU Business Continuity
Diamond Pharma Services (DPS) announce the opening of EU Headquarters in The Netherlands to maintain continuity of services through the Brexit process. The opening of Diamond Pharma Services B.V. also adds to our existing EU office in Sofia, increasing our footprint in continental Europe.
Read MoreQPPV
EEA & UK Qualified Person for Pharmacovigilance (QPPV) services for licensed and unlicensed products.